Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

    • George Freeman

    - PMLiVE

    Common antidiabetic drug metformin found to slow growth of precancerous cells

    The findings suggest that the drug could be used to manage squamous oesophageal cancer risk

    - PMLiVE

    Alzheimer’s Research UK awards Scottish universities £100,000 for dementia research

    The neurological condition affects more than 944,000 people in the UK

    - PMLiVE

    UK study reveals significantly higher risk of second cancers among breast cancer survivors

    Breast cancer is currently the most commonly diagnosed cancer in the UK, affecting around 56,000 people annually

    - PMLiVE

    UK universities awarded over £58m by Cancer Research UK for clinician scientist training

    The funding builds on the charity’s previous Clinical Academic Training Programme Award investment in 2019

    - PMLiVE

    ICR study shows how dormant breast cancer cells can be targeted to prevent relapse

    Oestrogen receptor positive breast cancer accounts for up to 80% of all breast cancers cases

    - PMLiVE

    Study suggests health and lifestyle factors could be linked to young-onset dementia

    There are around 370,000 new cases of young-onset dementia globally every year

    - PMLiVE

    Cancer Research UK and Guardant collaborate to advance cancer detection and treatment

    The partnership aims to accelerate the development of cancer drugs and diagnostics

    - PMLiVE

    Cancer Research UK calls on government to create ten-year cancer plan

    The charity estimates that around 20,000 annual cancer deaths in the UK could be prevented by 2040

    - PMLiVE

    New genetic variants linked to prostate cancer in men with African ancestry

    A dataset was compiled for the research containing DNA from over 944,000 men

    - PMLiVE

    New £5m project launched to bring Alzheimer’s blood tests to the NHS

    Blood tests for the condition could become available on the NHS within five years

    - PMLiVE

    Cancer Research UK and KWF Dutch Cancer Society partner for drug development

    More than 390,000 people are diagnosed with cancer every year in the UK

    - PMLiVE

    Alzheimer’s Research UK survey highlights dementia knowledge gaps

    The UK poll revealed that only 60% of adults know that dementia is a cause of death

    Subscribe to our email news alerts

    Latest content

    Latest intelligence

    Quick links